Development And Validation Of Liquid Chromatography-Mass Spectrometry Method For The Determination Of Telmisartan In Human Plasma
Bm Chen,Yz Liang,Yl Wang,Fl Deng,P Zhou,Fq Guo,Lf Huang
DOI: https://doi.org/10.1016/j.aca.2005.03.004
IF: 6.911
2005-01-01
Analytica Chimica Acta
Abstract:A sensitive liquid chromatographic-electrospray ionization mass spectrometric method was developed and validated for fast determination of telmisartan in human plasma. Plasma of 0.1 mL was deprotienated with methanol, centrifugation, evaporation to dryness and dissolving in mobile phase, samples were separated using a Hypersil-Keystone C18 reversed-phase column (150 mm x 2.1 mm i.d., 5 mu m), together with a mobile phase containing of acetonitrile-10 mM ammonium acetate (42:58, v/v), 0.2% acetic acid and was isocratically eluted at a flow rate of 0.2 mL/min. Telmisartan and its internal standard, valsartan, were measured by electrospray ion source in positive selective ion monitoring mode. The method demonstrated linearity from 1 to 2000 ng/mL (r = 0.9988). The limit of quantification for telmisartan in plasma was 1 ng/mL with good accuracy and precision. The mean sample extract recovery of the method were higher than 82 and 78% for telmisartan and internal standard (IS), respectively. The within-run and between-run precision ranged from 3.4 to 8.9% and 5.9 to 11.2% (relative standard deviation, R.S.D.), respectively. (c) 2005 Elsevier B.V. All rights reserved.